| Literature DB >> 34924764 |
Hanh Vu1, Masahiro Hayashi2,3, Thang Nam Nguyen4, Diep Thi Khong4, Hoa Thi Tran4, Yoshimasa Yamamoto1, Kaori Tanaka1,2,3.
Abstract
PURPOSE: Normal non-pathogenic flora can harm the host by acting as a reservoir of resistance determinants that are potentially transferable to human pathogens. This study aimed to assess the phenotypic and genotypic antimicrobial susceptibility patterns of the Bacteroides fragilis group (BFG) isolated from healthy individuals in Vietnam and Japan in order to elucidate the prevalence of antimicrobial resistance in human flora in the two economically and geographically different countries.Entities:
Keywords: antimicrobial resistance patterns; human flora; resistance genes
Year: 2021 PMID: 34924764 PMCID: PMC8674666 DOI: 10.2147/IDR.S341571
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Identification of Isolations from Form Healthy Individuals in Vietnam and Japan
| Species | Number of Isolations | |
|---|---|---|
| Vietnam | Japan | |
| 1 | 0 | |
| 0 | 1 | |
| 3 | 9 | |
| 5 | 15 | |
| 9 | 5 | |
| 15 | 6 | |
| 1 | 1 | |
| 2 | 0 | |
| 27 | 10 | |
| 0 | 2 | |
| 13 | 14 | |
Minimum Inhibitory Concentration (MIC) of 18 Antimicrobial Agents Against BFG Isolations from Healthy Individuals in Vietnam and Japan
| Antimicrobial Agents | Resistant Breakpoint (µg/mL)a | Vietnam (n=76) | Japan (n=63) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MIC Range (µg/mL) | MIC50 (µg/mL) | MIC90 (µg/mL) | %Rc | MIC Range (µg /mL) | MIC50 (µg/mL) | MIC90 (µg/mL) | %Rd | (c and d) | ||
| Ampicillin | ≥ 2 | 16 to >128 | >128 | >128 | 100 | 8 to >128 | >128 | >128 | 100 | _ |
| Ampicillin/sulbactam | ≥ 32/16 | 0.5 to 64 | 8 | 32 | 17.1 | 1 to 32 | 8 | 32 | 7.9 | 0.109 |
| Piperacillin | ≥ 128 | 2 to >128 | >128 | >128 | 75 | 4 to >128 | 128 | >128 | 50.8 | 0.003 |
| Piperacillin/tazobactam | ≥ 128/4 | ≤0.015 to 128 | 4 | 16 | 1.3 | ≤0.015 to 32 | 4 | 16 | 0 | 0.361 |
| Cefazolin | _ | 16 to >128 | >128 | >128 | _ | 8 to >128 | 128 | >128 | _ | _ |
| Cefmetazole | ≥ 64 | 8 to >128 | 64 | >128 | 61.8 | 2 to >128 | 32 | 128 | 41.3 | 0.016 |
| Ceftriaxone | _ | 16 to >128 | >128 | >128 | _ | 4 to >128 | >128 | >128 | _ | _ |
| Ceftazidime | _ | ≥128 | >128 | >128 | _ | 32 to >128 | >128 | >128 | _ | _ |
| Meropenem | ≥ 16 | 0.25 to 16 | 0.5 | 2 | 1.3 | 0.125 to 16 | 0.25 | 2 | 1.6 | 0.894 |
| Metronidazole | ≥ 16 | 0.25 to 4 | 1 | 2 | 0 | 0.25 to 2 | 1 | 1 | 0 | _ |
| Clindamycin | ≥ 8 | 0.03 to >128 | >128 | >128 | 78.9 | ≤ 0.015 to >128 | >128 | >128 | 57.1 | 0.006 |
| Clarithromycin | _ | 0.5 to >128 | >128 | >128 | _ | 0.25 to >128 | >128 | >128 | _ | _ |
| Erythromycin | _ | 2 to >128 | >128 | >128 | _ | 1 to >128 | >128 | >128 | _ | _ |
| Tetracycline | ≥ 16 | 0.25 to 128 | 32 | 64 | 90.8 | 0.125 to 128 | 16 | 64 | 65.1 | < 0.001 |
| Minocycline | ≥ 16b | ≤0.015 to 32 | 4 | 16 | 17.1 | ≤0.015 to 32 | 4 | 8 | 4.8 | 0.023 |
| Levofloxacin | _ | 0.5 to 64 | 4 | 32 | _ | 0.5 to 64 | 4 | 32 | _ | _ |
| Ciprofloxacin | _ | 4 to 128 | 16 | 64 | _ | 4 to >128 | 16 | 128 | _ | _ |
| Sulfamethoxazole | _ | 64 to >128 | >128 | >128 | _ | 32 to >128 | >128 | >128 | _ | _ |
Notes: aResistant breakpoints from Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility testing. 30th ed. CLSI supplement M100. bThe breakpoint of tetracycline was used to calculate the resistance percentage of minocycline. c,dPercentage of resistant isolations to antibiotics based on CLSI in Vietnam and Japan, respectively. c,dColumn values were used to calculate the P value at the last column.
Distribution of Antibiotic Resistance Genes in B. fragilis and Other Bacteroides in Vietnam and Japan
| Number of Resistance Genes (%) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | ||||||||||||||||
| 3 | 3 (100) | 0 (0) | 0 (0) | 3 (100) | 0 (0) | 3 (100) | 0 (0) | _ | 3 (100) | 0 (0) | _ | 0 (0) | 0 (0) | 0 (0) | ||
| Non-fragilis | 73 | 3 (4.1) | 37 (50.7) | 4 (5.5) | 29 (39.7) | 5 (6.8) | 25 (34.2) | 2 (2.7) | _ | 59 (80.8) | 11 (15.1) | _ | 13 (17.8) | 1 (1.4) | 5 (6.8) | |
| 6 (7.9) | 37 (48.7) | 4 (5.26) | 32 (42.1) | 5 (6.6) | 28 (36.8) | 2 (2.6) | 0 (0) | 62 (81.6) | 11 (14.5) | 0 (0) | 13 (17.1) | 1 (1.3) | 5 (6.6) | |||
| 9 | 8 (88.9) | 2 (22.2) | 0 (0) | 5 (55.5) | 0 (0) | 2 (22.2) | 0 (0) | 0 (0) | 9 (100) | 0 (0) | 0 (0) | 0 (0) | _ | _ | ||
| Non-fragilis | 54 | 1 (1.8) | 23 (42.6) | 3 (5.56) | 23 (42.6) | 19 (36.1) | 8 (14.8) | 9 (16.7) | 4 (7.4) | 38 (70.4) | 8 (14.8) | 1 (1.9) | 6 (11.1) | _ | _ | |
| 9 (14.3) | 25 (39.7) | 3 (4.8) | 28 (44.4) | 19 (35.2) | 10 (15.9) | 9 (14.3) | 4 (6.3) | 47 (74.6) | 8 (12.7) | 1 (1.6) | 6 (9.5) | 0 (0) | 0 (0) | |||
| 0.227 | 0.288 | 0.892 | 0.781 | <0.001 | 0.006 | 0.012 | 0.026 | 0.319 | 0.761 | 0.270 | 0.195 | 0.361 | 0.038 | |||
Notes: cepA, cfxA, cfiA: β-lactamase resistance genes. ermB, ermF, ermG, limA, mefA, msrSA: macrolide–lincomycin–streptogramin (MLS) resistance genes. tetM, tetQ, tetX, tetX1, tet36: tetracycline resistance genes. bexA, qnrA, qnrB, qnrS are quinolone resistance genes. nim: metronidazole resistance genes. catA:chloramphenicol resistance gene. ErmB, tet36, tetM, nim, catA, and qnrA were not found in either country. a,bAre percentage of resistant gene positive strains in Vietnam and Japan, respectively. a,bAre used for calculating the P value in the last row.
Figure 1The distribution of cepA, cfxA, and cfiA in BFG strains in Vietnam and Japan based on MIC values for ampicillin.
Figure 2The distribution of resistance genes responsible for tetracycline resistance (tetQ, tetX, tetX1) found in Bacteroides strains in Vietnam and Japan based on MIC values for tetracycline and minocycline. (A) MIC values for tetracycline in Vietnam and Japan (µg/mL). (B) MIC values for minocycline in Vietnam and Japan (µg/mL).